Sunshine Pictures Limited SUNSHINE NSE
Company Overview
Sunshine Pictures Limited engages in the business of film production, content development, media distribution, and allied entertainment services in India. The company offers production of feature films, web series, and television content. It is also involved in music production and distribution. It serves the entertainment industry by creating and distributing diverse media content across various platforms. Sunshine Pictures Limited was incorporated in 2007 and is based in Mumbai, India.
Why Investors Should Care
Generates a return on equity of 27.6%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 37.8%.
Net profit has compounded at 158.7% per year over the last five years.
Revenue has grown at a 41.1% CAGR over the past five years.
Maintains a net profit margin of 53.8%.
Carries low leverage with a debt-to-equity ratio of 0.07.
Recent Developments
- Mar 2026 Revenue of ₹74.44 Cr (-28.0% YoY); net profit ₹40.02 Cr.
- Trailing 12 Months Year-on-year growth — revenue -28.0%, earnings +16.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 41.1%, profit CAGR 158.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 41.08% |
| 1 Year: | -27.96% |
Compounded Profit Growth
| 5 Years: | 158.72% |
| 1 Year: | 16.13% |
Stock Price Performance
| 1 Year: | +11.13% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | -4.60% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- RSI (14)40.47 · Neutral
P/E of 31.93 is above the sector median of 21.11 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 27.6%.
- Healthy ROCE of 37.8%.
- Excellent profit margin of 53.8%.
- Compounding revenue at 41.1% over 5 years.
- Profit CAGR of 158.7% over 5 years.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Communication Services).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SUNSHINE Sunshine Pictures Limited NSE | 410.30 | 31.93 | ₹1,278.03 Cr | 0.00% | 37.83% | 27.58% | 41.08% | 158.72% |
| 2 | BHARTIARTL Bharti Airtel Limited NIFTY50NSEAI | 1,891.70 | 39.53 | ₹11.80 L Cr | 1.31% | 16.69% | 20.15% | 14.88% | 47.34% |
| 3 | IDEA Vodafone Idea Limited NIFTY_MIDNSE | 11.64 | 3.37 | ₹1.26 L Cr | 0.00% | 36.90% | -96.63% | 2.05% | 72.64% |
| 4 | INDUSTOWER Indus Towers Limited NIFTY_MIDNSE | 379.00 | 13.97 | ₹99,949.98 Cr | 3.64% | 18.39% | 18.91% | 4.61% | 51.86% |
| 5 | BHARTIHEXA Bharti Hexacom Limited NIFTY_MIDNSE | 1,629.30 | 44.68 | ₹81,465.00 Cr | 1.20% | 21.11% | 24.19% | 12.45% | 46.68% |
| 6 | NAUKRI Info Edge (India) Limited NIFTY_MIDNSEAITECH | 1,235.20 | 50.09 | ₹80,008.55 Cr | 1.18% | 4.71% | 3.82% | 11.88% | 483.26% |
| 7 | TATACOMM Tata Communications Limited NIFTY_MIDNSEAI | 1,691.70 | 51.05 | ₹48,227.94 Cr | 1.05% | 15.29% | 29.06% | 11.58% | -17.69% |
| 8 | SUNTV Sun TV Network Limited NIFTY_SMALLNSE | 627.15 | 16.15 | ₹24,715.02 Cr | 3.26% | 15.31% | 11.39% | 4.74% | -5.51% |
| 9 | PFOCUS Prime Focus Limited NSE | 275.50 | 154.78 | ₹21,455.22 Cr | 0.00% | 24.91% | 10.47% | -0.29% | 14.09% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Jun 2025 | Sep 2025 | Jun 2026 |
|---|---|---|---|
| Revenue | 69.38 Cr | -66.33 Cr | 6.48 Cr |
| Cost of Revenue | 13.55 Cr | -13.48 Cr | 4.80 Cr |
| Gross Profit | 55.83 Cr | -52.85 Cr | 1.68 Cr |
| Operating Expenses | 1.91 Cr | 91.06 L | 1.26 Cr |
| Operating Income | 53.92 Cr | -53.76 Cr | 41.62 L |
| EBITDA | 54.78 Cr | -52.08 Cr | 1.03 Cr |
| Interest Expense | 73.19 L | 96,000 | 16.74 L |
| Pretax Income | 53.37 Cr | -52.75 Cr | 34.24 L |
| Tax Provision | 13.66 Cr | -13.45 Cr | 8.94 L |
| Net Income | 39.71 Cr | -39.30 Cr | 25.30 L |
| Diluted EPS | 12.75 | - | 0.08 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 26.51 Cr | 133.80 Cr | 103.33 Cr | 74.44 Cr |
| Cost of Revenue | 18.91 Cr | 62.24 Cr | 50.98 Cr | 13.62 Cr |
| Gross Profit | 7.60 Cr | 71.56 Cr | 52.35 Cr | 60.81 Cr |
| Operating Expenses | 4.74 Cr | 5.47 Cr | 6.73 Cr | 6.51 Cr |
| Operating Income | 2.86 Cr | 66.09 Cr | 45.63 Cr | 54.31 Cr |
| EBITDA | 4.46 Cr | 73.95 Cr | 50.71 Cr | 58.51 Cr |
| Interest Expense | 13.59 L | 66.08 L | 1.70 Cr | 1.72 Cr |
| Pretax Income | 3.12 Cr | 71.06 Cr | 46.23 Cr | 54.06 Cr |
| Tax Provision | 80.78 L | 17.72 Cr | 11.76 Cr | 14.04 Cr |
| Net Income | 2.31 Cr | 53.35 Cr | 34.46 Cr | 40.02 Cr |
| Diluted EPS | 0.74 | 17.13 | 11.06 | 12.85 |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 38.57 Cr | 97.38 Cr | 131.28 Cr | 179.64 Cr |
| Current Assets | - | 20.68 Cr | 62.24 Cr | 99.13 Cr | 151.68 Cr |
| Cash & Equivalents | - | 36.19 L | 1.33 Cr | 11.64 Cr | 48.25 L |
| Inventory | - | 16.41 Cr | 24.32 Cr | 24.08 Cr | 75.06 Cr |
| Receivables | - | 0 | 7.97 Cr | 28.39 Cr | 66.51 Cr |
| Total Liabilities | - | 11.26 Cr | 26.78 Cr | 26.21 Cr | 34.50 Cr |
| Current Liabilities | - | 11.14 Cr | 26.55 Cr | 23.48 Cr | 32.18 Cr |
| Long Term Debt | - | - | 0 | 2.18 Cr | 1.66 Cr |
| Total Debt | - | 6.68 Cr | 16.90 Cr | 11.44 Cr | 9.46 Cr |
| Total Equity | - | 27.30 Cr | 70.60 Cr | 105.07 Cr | 145.13 Cr |
| Shares Outstanding | - | 3.11 Cr | 3.11 Cr | 3.11 Cr | 3.11 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating Cash Flow | -5.01 Cr | 31.60 Cr | 28.47 Cr | -33.21 Cr |
| Investing Cash Flow | -4.48 Cr | -29.97 Cr | -10.81 Cr | 25.94 Cr |
| Financing Cash Flow | 6.32 Cr | -65.84 L | -7.35 Cr | -3.90 Cr |
| Capital Expenditure | -5.03 Cr | -12.04 Cr | -5.22 Cr | -42.21 L |
| Free Cash Flow | -10.03 Cr | 19.56 Cr | 23.25 Cr | -33.63 Cr |
| Net Change in Cash | -3.17 Cr | 97.03 L | 10.31 Cr | -11.16 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Gross Margin % | 28.7% | 53.5% | 50.7% | 81.7% |
| Operating Margin % | 10.8% | 49.4% | 44.2% | 73.0% |
| Net Margin % | 8.7% | 39.9% | 33.4% | 53.8% |
| ROE % | 8.5% | 75.6% | 32.8% | 27.6% |
| ROCE % | 10.4% | 93.3% | 42.3% | 36.8% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SUNSHINE
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQRG9RYmtMZzhVb0lSUV9OcjRnSmFQR3ZPNDlLQk00dlZ2WkFwajhjcTJkYXBuVldXNldCcjJRRkw5blFMelItSDlDWHhiZGVqaFVJampDSHJmUzZrMVU2TGNwUjlxb09vX01MTC1qYmY4WEcyNFcxZGIzR01PeWJkWTZmaklYWW95b3F1NG…
Sunshine Biopharma announces reverse stock split to maintain Nasdaq listing - TradingView
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxOLVJBUFl0eWNhd215VnZmbjBsUVVON05BNW5pUUFUR3V2QUV4NllOcnY1dGVhb0t2T3FPY1JtdWY2Yl9TeUNfeXJyNjZRRDZtdVNwMEdYUnp3dEVKVGRzVFVGWVZveHhLVW02U212Um83Z3JFeWFCYktIaWxyc0F0OExuM1FNR2dJdEhZYX…
Sunshine Biopharma Announces 1-for-20 Reverse Stock Split to Regain Nasdaq Compliance - citybiz
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxOZVVLeWRyQlFOQXBrb254LVViZGpZM01xc3NRdTV5a2Fud1Z6bjFLVmFIZkJySWQtUVV1VmNncTQ0ZF8wRXpIbXlTVEtyOXhMbDk1ejZDYVg2RUVFdXZtVnUxX0kwRmtNZVFrUS1fSjdPalV4ODNHbXQ5UWhlY0dfdVR4MkpOY1luYVFGaW…
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing - The Batesville Daily Guard
<a href="https://news.google.com/rss/articles/CBMi-wFBVV95cUxNM1dUaVlwSjFrRUdEN0dXY1BYTWxURmt2R2xpRHp6aENROUdETld5ZUVlSGtkSERWUUd2WTYydk5tR3FvbTA4aGNnbkZsNWFGdjh0S1RsU056NFBETDVUWVd2QWM5QVp0Yi0wMHk2WEE5QlV4SG55ZXBINEl4NDJfY1R5WXRDRjZrS1E1RG…
Sunshine Biopharma Announces Reverse Stock Split to Maintain NASDAQ Listing - Corsicana Daily Sun
<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxPdnpOVk1NOXhFdUUwZ0ZsQjFzbTFudVZzcVFMVWY0MzNEQ1FWNkRrWDZYQ0xMaUxJYjJna0RPd1FsTUs2bTNjUEU0RU9rN091MHQweS1LRGdFNWRPNzhCYTJWY2lYeXE1Yi1salJWVzkwU2o3TmdGUTE0UDR5aHB5c1pwUC13NHhGYVpxWV…
Sunshine Biopharma announces 1-for-20 reverse stock split - Investing.com India
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNZDM3TTNmTzFsNkdFY0hscnZoa1JmSU1MU05RSFNTZnVQbkYzdjVUaE0wSEZXS1V3cEhiQS14aXIzaVNabS1FVl9LS3lZR1JPTDZzc3lmc09rc1hTTDYxemJGcF9rU2YxSzMwSkM4eW1OMXFzcExDLXlYOW9VNnkycmM4eFQ5UEtBWWsxRU…
SUNSHINE — Frequently Asked Questions
What is the current share price of Sunshine Pictures Limited (SUNSHINE)?
As of 2026-10-23 04:58 IST, Sunshine Pictures Limited (SUNSHINE) trades at ₹410.30 on NSE. Its 52-week range is ₹333.95 to ₹509.70.
What is the market capitalisation of SUNSHINE?
Sunshine Pictures Limited (SUNSHINE) has a market capitalisation of ₹1,278.03 Cr on NSE.
What is the P/E ratio of SUNSHINE?
SUNSHINE trades at a trailing price-to-earnings (P/E) ratio of 31.93. The industry average P/E is 21.11. Its price-to-book (P/B) ratio is 9.38.
What is the return on equity (ROE) of SUNSHINE?
SUNSHINE has a return on equity (ROE) of 27.58%. Its return on capital employed (ROCE) is 37.83%.
Is SUNSHINE a good stock to buy?
This page provides a data-driven analysis of Sunshine Pictures Limited (SUNSHINE), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.